Patents
Patents for C07C 61 - Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings (2,686)
03/2009
03/18/2009EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
03/10/2009US7501539 2-(1-hydroxyalkyl)-cyclopent-2-en-1-one derivative starting material is thermally rearranged to a 2-alkylidene-3-oxo-cyclopentylacetate derivative; intermediates to perfumes such as methyl jasmonate
03/05/2009WO2008149370A3 Oxidation of aldehydes and alkenes
03/05/2009US20090062384 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease
02/2009
02/26/2009US20090054648 Method for producing asymmetric tetrasubstituted carbon atom-containing compound
02/26/2009US20090054506 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
02/24/2009US7494642 Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits
02/19/2009US20090047223 Improvements in or Related to Organic Compoounds
02/18/2009CN101367722A Preparation of pyrethroid midbody
02/17/2009US7491844 Therapeutic cyclopentane derivatives
02/05/2009WO2009015504A2 Mono- or bicyclic carboxylic acids as off-note blockers
02/05/2009WO2008132128A3 Synthesis of a pharmaceutically active compound
01/2009
01/21/2009CN101347502A Effective component of selfheal and preparation and use thereof
01/13/2009US7476755 e.g. 5-(3-{(1S,2S)-2-[4-(1-Hydroxy-hexyl)-phenyl]-3-oxo-cyclopentyl}-propyl)-thiophene-2-carboxylic acid; prostaglandin receptor ligand; antiinflammatory agent; glaucoma or ocular hypertension
01/08/2009US20090012318 Cage-shaped cyclobutanoic dianhydrides and process for production thereof
01/07/2009EP2010475A2 Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
12/2008
12/31/2008EP1558230B1 Spirocyclopropyl amides and acids and their therapeutic applications
12/31/2008CN101336232A 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids
12/25/2008US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
12/24/2008CN100445293C Supermolecular carboplatinum derivatives, their preparation method, and pharmaceutical composition containing them as active ingredient and applications of the composition
12/23/2008US7468389 Cyclopropane carboxylic acid for treatment of nervous system disorders and for slowing metabolism
12/18/2008US20080311631 Biosynthetic Production of 4-Amino 4-Deoxychorismate (Adc) and [3R,4R]-4-Amino-3-Hydroxycyclohexa-1,5-Diene-1-Carboxylic Acid (3,4-Cha)
12/17/2008EP2003113A1 Process for production of carboxylic acid chloride compound
12/16/2008US7465415 Reaction product of a ring-opening cyclic ester or carbonate and a photochromic initiator, especially a naphtho[1,2-b]quinone with one or more hydroxy groups, e.g., (1) 3,3-di(4-methoxyphenyl)-6,7-dimethoxy-13-methyl-13-(2-(2-hydroxyethoxy)ethoxy)-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran.
12/11/2008WO2008149370A2 Oxidation of aldehydes and alkenes
12/11/2008WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008WO2008024892A3 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/11/2008CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/04/2008WO2007127440A3 Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
12/04/2008WO2007124435A3 Detection of histone deacetylase inhibition
12/04/2008US20080299238 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease
12/03/2008EP1997816A1 Heterodiamondoids
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
11/2008
11/27/2008US20080293728 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/19/2008EP1991612A2 Nucleating agent additive compositions and methods
11/19/2008CN101309950A Tetracarboxylic acid-based compound, its polyimide, and its manufacturing method
11/13/2008WO2008103319A3 Compounds and methods for use in detecting gabapentin
11/12/2008CN101302151A Preparation of isopimaric acid
11/06/2008WO2008132720A1 Biocidic textiles and fabrics
11/06/2008WO2008132128A2 Synthesis of a pharmaceutically active compound
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
10/2008
10/30/2008US20080269517 Process for the preparation of acid halides
10/29/2008EP1985603A1 Process for preparing difluorocyclohexanoic acid derivatives
10/28/2008US7442829 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/22/2008EP1982970A1 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
10/22/2008CN100427452C Method of preparing 1,1-cyclohexanepentanedioic acid by catalyst-free hydrolyzing alpha,alpha'-dicyano-1,1-1,1-cyclohexanediacetylimide ammonium salt in near-critical water medium
10/21/2008US7439387 Process for the preparation of Gabapentin form-II
10/21/2008US7439372 Therapeutic compounds
10/16/2008US20080255367 Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates
10/15/2008EP1628656B1 Gabapentin tannate in liquid and/or semi-solid dosage forms
10/14/2008US7435848 Catalytically hydrogenating aromatic carboxylic acid, ester, or anhydride with hydrogen gas in the presence of a fixed bed catalyst in at least three series-connected hydrogenation units, the first two of which are operated in loop operating mode and have different residence times; continuous processing
10/09/2008US20080249166 Inhibiting hepatic fatty acid and sterol synthesis; use with statins; compounds such as cyclopropyl or cyclobutyl-functional hydroxy-functional alpha,gamma-alkanediacids
10/08/2008CN100424062C Process for preparing hydroaromatic polybasic carboxylic acid and process for preparing hydroaromatic polybasic carboxylic anhydride
09/2008
09/25/2008US20080234499 Synthesising Method and Benzoxathiepine Intermediates
09/18/2008US20080227118 Protein Immobilization Method and Quantification Method
09/18/2008US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
09/16/2008US7425651 Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof
09/16/2008US7425646 Excellent in physical properties such as heat resistance, light resistance, chemical resistance, low refractive index properties, water repellency, oil repellency and transparency
09/10/2008EP1966135A2 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids
09/10/2008EP1373396B1 Highly nucleated thermoplastic articles
09/04/2008US20080214853 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
09/04/2008US20080214851 Synthesis of labeled fatty acid analogs for use in tomography
09/04/2008US20080214670 Therapeutic Malonic Acid/Acetic Acid C60 Tri-Adducts of Buckminsterfullerene and Methods Related Thereto
09/04/2008US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1
09/04/2008US20080213178 Using a radiolabeled fatty acid analog such as endo-[18F] fluoro- or [123I]iodo-3,4-cyclopropylheptadecanoic acid localized in tissue of interest, imaging, determining blood flow rate
09/04/2008US20080213173 Labeled fatty acid analogs; tissue-targeted therapy; tomography; block the catabolic pathway, thus trapping these analogs in a virtually unmodified form in the tissues of interest such as heart, liver, or tumor; endo-vinylic variants of cycloalkyl-substituted heptadecanoic acid for example
09/03/2008CN101255350A Technique for comprehensive treatment of diesel oil alkaline residue by using circulating technology
09/03/2008CN101255106A Method for intensified neutral oil removal of diesel alkaline residue and step reclamation of naphthenic acids and phenols
09/03/2008CN101255105A Method for step reclamation of naphthenic acids and phenols from diesel alkaline residue
09/02/2008US7420086 Process for producing trans-1,4-cyclohexanedicarboxylic acid
09/02/2008US7420082 Including an optimized post-digestion cooling stage that provides a terephthalic acid product having enhanced purity, while minimizing costs associated with removing impurities from recycled solvent.
08/2008
08/28/2008US20080206135 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
08/27/2008EP1961737A1 Indan-1,3-carbodinitrile dervatives
08/27/2008CN101250100A Preparation of novel flavoring agents capable of remarkably intensifying tobacco fragrance and smoking smell
08/26/2008US7417166 Process for the preparation of gabapentin
08/20/2008EP1622602B1 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
08/13/2008EP1955993A1 Quaternary trifluoromethylcyclohexane derivatives for liquid crystals
08/12/2008US7411031 Synthesis of polyanhydrides
08/07/2008WO2008092955A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
08/07/2008US20080188475 Perhydro- or hydrophenanthrene derivatives; antiinflammatory, analgesic, anticarcinogenic, and antitumor agents; autoimmune, skin, cardiovascular, and viral diseases
08/07/2008CA2677173A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
07/2008
07/31/2008US20080183011 Isolating perindopril erbumine alpha crystalline form from solvent such as benzene, toluene, xylene or mixture of toluene and ethyl acetate or mixture of ethyl acetate & benzene, purity; angiotensin-converting enzyme (ACE) inhibitors
07/31/2008US20080183003 Neuroprotective agents; nitrate-functional, for example 1-amino-3,5-dimethyl-7-nitrateadamantane hydrochloride
07/30/2008CN100406428C Method for hydrogenating benzene polycarboxylic acids or derivatives thereof by using catalyst containing macropores
07/23/2008EP1565421B1 A method for preparing indan-1,3-dicarboxylic acid
07/22/2008US7402835 Heteroatom-containing diamondoid transistors
07/08/2008US7396955 Annealed and promoted catalyst
07/08/2008US7396946 Compound for treatment of external secretion disorders
07/01/2008US7393975 Process for the purification of gabapentin
07/01/2008US7393974 Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
06/2008
06/26/2008WO2008074677A1 Process for preparing 1- (2-ethyl-butyl) -cyclohexanecarboxylic acid
06/26/2008US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists
06/26/2008CA2672505A1 Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid
06/25/2008EP1935867A1 Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid
06/19/2008US20080146832 Microporous catalyst and method for hydrogenating aromatic compounds
06/19/2008US20080145322 picene (benzo[a,i]chrysene) carboxylic acid derivatives; bactericide; with other antimicrobial agent or antibiotic; prostatitis, biliary tract infections, urinary tract infections, cystitis, lung infections, sinus infections, ear infections, acne, rosacea, dental caries, periodontitis
06/18/2008CN101203477A Mixture of diisononyl esters of 1,2-cyclohexanedicarboxylic acid, method for the production thereof and use of these mextures
06/17/2008CA2444053C Fused bicyclic or tricyclic amino acids
06/11/2008CN100393773C Hydrogenation of polyester oligomers containing terephthalic acid residues
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 27